Kontrobersiyal na Pharmally Pharmaceutical, ‘di sa amin — Rose Lin

MANILA, Philippines — Hindi sister company ng Pharmally Biological and Pharmaceutical Company ang kontrobersiyal na Pharmally Pharmaceutical Corporation na sentro ng imbestigasyon ng House Quad Committee.

Ito ang ginawang paglilinaw ng negosyanteng si Rose Nono Lin, may-ari nang nabuwag na Pharmally Biological sa ginawang pagharap sa quad com.

Anya, bukod sa hindi sister company ng Pharmally Biological ang Pharmally Pharmaceutical, hindi rin siya naging opisyal o shareholder ng kontrobersiyal na pharmaceutical company.

Anya, ang nabuwag na Pharmally Biological ay hiwalay at iba sa Pharmally Pharmaceutical.

Ito rin anya ang ginawang paglilinaw niya sa Senate Blue Ribbon Committee noong 2021 nang imbestigahan ang P8 billion contract ng Pharmally Pharmaceutical para sa probisyon ng medical supplies noong panahon ng COVID-19 pandemic.

“I have no involvement in the operations of Pharmally Pharmaceutical Corp. Pharmally Biological is a different entity, and has no shares or stocks with Pharmally Pharmaceutical.I am just an ordinary citizen and businesswoman making a living in a legal and fair means. All the accusations against me and my family were purely hearsay,” sabi ni Rose Lin.

Unang lumabas sa report na ang asawa ni Rose Lin na si Lin Wei Xiong, isang Hong Kong national ay ang financial manager ng Pharmally Pharmaceutical at close associate ni dating presidential adviser Michael Yang, na nagpondo umano sa kumpanya.

“All these are speculations. She is not an officer [of Pharmally Pharmaceutical] nor involved in the operation or implementation of the contract,” ayon sa abogado ni Rose Lin.